Targeting solid tumors with non‐pathogenic obligate anaerobic bacteria

S Taniguchi, M Fujimori, T Sasaki, H Tsutsui… - Cancer …, 2010 - Wiley Online Library
Molecular‐targeting drugs with fewer severe adverse effects are attracting great attention as
the next wave of cancer treatment. There exist, however, populations of cancer cells …

Optimizing Molecular‐Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways

D Hiss - Journal of oncology, 2012 - Wiley Online Library
The hallmarks of ovarian cancer encompass the development of resistance, disease
recurrence and poor prognosis. Ovarian cancer cells express gene signatures which pose …

Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer

SF Martins, EA Garcia, MAM Luz… - Cancer genomics & …, 2013 - cgp.iiarjournals.org
Background: Colorectal cancer (CRC) is the third most common type of cancer and the
fourth most frequent cause of cancer death. Literature indicates that vascular endothelial …

[HTML][HTML] Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies

SF Martins, RM Reis, AM Rodrigues… - World Journal of …, 2011 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the cancer models and most of the carcinogenic steps are
presently well understood. Therefore, successful preventive measures are currently used in …

[HTML][HTML] Investigating impact of vascular endothelial growth factor polymorphisms in epithelial ovarian cancers: a study in the Indian population

B Janardhan, S Vaderhobli, R Bhagat… - PloS one, 2015 - journals.plos.org
Epithelial ovarian cancer is one of the increasingly incident malignancies that is notorious
because of its evasiveness for early diagnosis and high mortality rates. Epithelial ovarian …

[图书][B] Tumor angiogenesis regulators

RR Gonzalez-Perez, BR Rueda - 2013 - books.google.com
The emphasis of this book is on mechanisms and pathways regulating the expression and
actions of classical and novel tumor angiogenesis regulators. The contributors discuss their …

Utility of vascular endothelial growth factor inhibitors in the treatment of ovarian cancer: from concept to application

A Amini, S Masoumi Moghaddam, DL Morris… - Journal of …, 2012 - Wiley Online Library
Despite recent advances in the management of ovarian cancer, it remains the most lethal
gynecologic malignancy. Vascular endothelial growth factor (VEGF) has been shown to play …

[PDF][PDF] 恶性腹腔积液的靶向治疗进展*

苏杭, 胡冰 - 医药导报, 2016 - yydbzz.com
恶性腹腔积液是多种恶性肿瘤引起的液体在腹腔内异常积聚, 是肿瘤浸润和转移的突出临床表现
之一, 常提示肿瘤晚期. 目前针对恶性腹腔积液的治疗包括限钠利尿, 腹腔穿刺引流 …

[HTML][HTML] Факторы роста в ткани различных стадий рака яичников

ОИ Кит, ЕМ Франциянц, ТИ Моисеенко… - Медицинский …, 2017 - cyberleninka.ru
Изучены уровни эндотелиального фактора роста VEGF-A и его рецептора sVEGF-R1,
эпидермального фактора роста EGF и его рецептора sEGF-R, фактора некроза …